Viral Vectors Regulatory Support for Viral Vector

Viral Vector Regulatory Support Service

As viral vector-based therapies advance, regulatory complexity increases across development and commercialization. SK pharmteco provides regulatory support to help partners maintain compliance and align development and manufacturing activities with global regulatory expectations.

Regulatory strategy is integrated across all stages of viral vector development. SK pharmteco supports chemistry, manufacturing, and controls (CMC) activities, enabling efficient preparation of regulatory submissions and consistent alignment with agency requirements. Our teams help streamline interactions with global health authorities and support progression from early development through commercial manufacturing.

Our Regulatory Experience

SK pharmteco’s viral vector CDMO services are supported by an established global regulatory track record:

0 %

inspection pass rate across all facilities

✓

Global compliance across major regulatory agencies

successful pre-approval inspections over the past decade

0 +

successful customer audits annually

Supporting Programs from Development Through Commercialization

From early development through commercial manufacturing, regulatory activities are coordinated with process development, analytical testing, and CGMP production. This alignment supports consistent documentation, reduces risk during scale-up, and facilitates regulatory approvals.

Submission Strategy and Execution

SK pharmteco provides regulatory support across all CMC activities, including specification setting, method development and validation, process qualification (PPQ), and continued process verification. Our teams support preparation, review, and lifecycle management of regulatory documentation, including:

IND / IMPD submissions
BLA and MAA submissions
Amendments and supplements
Briefing documents for regulatory interactions

Support also includes inspection readiness, mock inspections, and vendor compliance oversight to ensure alignment with global regulatory expectations.

Global Regulatory Engagement

SK pharmteco supports interactions with global health authorities throughout development. Our regulatory teams help prepare and guide sponsor participation in key regulatory meetings, including:

INTERACT, pre-IND, and pre-BLA meetings
End-of-phase meetings
Breakthrough therapy and PRIME interactions
Type A, B, and C meetings

These engagements support alignment on development strategy, CMC expectations, and submission pathways.

Integrated Quality Systems

Our global quality management system supports regulatory compliance across development and manufacturing. Digital systems enable real-time data capture, electronic batch records, and traceability across processes. This infrastructure supports control of critical process parameters, chain of identity, and consistent data generation for regulatory submissions.

Inspection Readiness & Compliance

SK pharmteco maintains a strong regulatory inspection record, supported by purpose-built facilities and established quality systems. All sites operate in compliance with global regulatory standards, with a 100% inspection pass rate and extensive experience supporting pre-approval inspections. This foundation enables reliable execution of viral vector manufacturing programs.

Viral Vector Regulatory Support FAQs

Contact us

We’re committed to supporting your development and manufacturing needs. Complete the form and someone from SK pharmteco will be in touch shortly.